Back

prof. dr. M. Koopman

Full Professor

  • Department of Medical Oncology

Research Output (136)

Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients

Kurk Sophie, Peeters Petra, Stellato Rebecca, Dorresteijn B, de Jong Pim, Jourdan Marion, Creemers Geert-Jan, Erdkamp Frans, de Jongh Felix, Kint Peter, Simkens Lieke, Tanis Bea, Tjin-A-Ton Manuel, Van Der Velden Ankie, Punt Cornelis, Koopman Miriam, May Anne 15 mei 2019, In: Journal of Cachexia, Sarcopenia and Muscle. 10 , p. 803-813 11 p.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases:protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Rovers Koen P, Bakkers Checca, Simkens Geert A A M, Burger Jacobus W A, Nienhuijs Simon W, Creemers Geert-Jan M, Thijs Anna M J, Brandt-Kerkhof Alexandra R M, Madsen Eva V E, Ayez Ninos, de Boer Nadine L, van Meerten Esther, Tuynman Jurriaan B, Kusters Miranda, Sluiter Nina R, Verheul Henk M W, van der Vliet Hans J, Wiezer Marinus J, Boerma Djamila, Wassenaar Emma C E, Los Maartje, Hunting Cornelis B, Aalbers Arend G J, Kok Niels F M, Kuhlmann Koert F D, Boot Henk, Chalabi Myriam, Kruijff Schelto, Been Lukas B, van Ginkel Robert J, de Groot Derk Jan A, Fehrmann Rudolf S N, de Wilt Johannes H W, Bremers Andreas J A, de Reuver Philip R, Radema Sandra A, Herbschleb Karin H, van Grevenstein Wilhelmina M U, Witkamp Arjen J, Koopman Miriam, Haj Mohammad Nadia, van Duyn Eino B, Mastboom Walter J B, Mekenkamp Leonie J M, Nederend Joost, Lahaye Max J, Snaebjornsson Petur, Verhoef Cornelis, van Laarhoven Hanneke W M, Kranenburg Onno, 25 apr 2019, In: BMC Cancer. 19

Randomised controlled trial for dose-escalated radiotherapy in locally advanced rectal cancer

Couwenberg A., Verkooijen H. M., Berbee M., Burbach J. P. M., Hoendervangers S., Reerink O., Philippens M. E. P., Consten E. C. J., Smits A. B., Heikens J., Wijffels N., Schiphorst A., Lacle M. M., Wessels F. J., Koopman M., Van Grevenstein W. M. U., Intven M. P. W. apr 2019, In: Radiotherapy and Oncology. 133 , p. S191-S191

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Kwakman Johannes J M, van Werkhoven Erik, Simkens Lieke H J, van Rooijen Johan M, van de Wouw Yes A J, Tije Albert J Ten, Creemers Geert-Jan M, Hendriks Mathijs P, Los Maartje, van Alphen Robbert J, Polée Marco B, Muller Erik W, van der Velden Ankie M T, van Voorthuizen Theo, Koopman Miriam, Mol Linda, Punt Cornelis J A 29 jan 2019, In: Clinical colorectal cancer. 18 , p. e229-e230

Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations:A Simulation Study and Illustration in Colorectal Cancer

Degeling Koen, Koffijberg Hendrik, Franken Mira D., Koopman Miriam, IJzerman Maarten J. 1 jan 2019, In: Medical Decision Making. 39 , p. 57-73 17 p.

Choosing the right strategy based on individualized treatment effect predictions:combination versus sequential chemotherapy in patients with metastatic colorectal cancer

Kwakman Johannes J.M., van Kruijsdijk Rob C.M., Elias Sjoerd G., Seymour Matthew T., Meade Angela M., Visseren Frank L.J., Punt Cornelis J.A., Koopman Miriam 1 jan 2019, In: Acta Oncologica. 58 , p. 326-333 8 p.

Angiogenesis in Y-90-Radioembolization of Colorectal Liver Metastases

Alsultan Ahmed A., Barentsz Maarten W., Smits Maarten L.J., Koopman Miriam, Lam Marnix G.E.H., Rosenbaum Charlotte E.N.M. 1 jan 2019, In: Seminars in nuclear medicine. 49 , p. 204-210 7 p.

Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer

Engelhardt Ellen G., Révész Dóra, Tamminga Hans J., Punt Cornelis J.A., Koopman Miriam, Onwuteaka-Philipsen Bregje D., Steyerberg Ewout W., De Vet Henrica C.W., Coupé Veerle M.H. 14 dec 2018, In: BMC Medical Informatics and Decision Making. 18 , p. 132

A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

Henricks Linda M., Lunenburg Carin A.T.C., de Man Femke M., Meulendijks Didier, Frederix Geert W.J., Kienhuis Emma, Creemers Geert Jan, Baars Arnold, Dezentjé Vincent O., Imholz Alexander L.T., Jeurissen Frank J.F., Portielje Johanna E.A., Jansen Rob L.H., Hamberg Paul, ten Tije Albert J., Droogendijk Helga J., Koopman Miriam, Nieboer Peter, van de Poel Marlène H.W., Mandigers Caroline M.P.W., Rosing Hilde, Beijnen Jos H., van Werkhoven Erik, van Kuilenburg André B.P., van Schaik Ron H.N., Mathijssen Ron H.J., Swen Jesse J., Gelderblom Hans, Cats Annemieke, Guchelaar Henk Jan, Schellens Jan H.M. 10 dec 2018, In: European Journal of Cancer. 107 , p. 60-67 8 p.

Matching the model with the evidence:comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients

Degeling Koen, Franken Mira D., May Anne M., van Oijen Martijn G.H., Koopman Miriam, Punt Cornelis J.A., IJzerman Maarten J., Koffijberg Hendrik 1 dec 2018, In: Cancer Epidemiology. 57 , p. 60-67 8 p.